Skip to content
Riskpilot
← Back to search
Sign in
Sign in
Get full access
Elos Medtech Timmersdala AB
AB
Active
Org 5560551201
Bäckedalsvägen 5, 541 71
Timmersdala
Manufacture of irradiation, electromedical and electrotherapeutic equipment
·
NACE 2660
Est. 1951 · 75 years old
47 employees
Monitor
Share
Sweden
/
Companies
/
Manufacture of irradiation, electromedical and electrotherapeutic equipment
/
Elos Medtech Timmersdala AB
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
SEK millions
143M
107M
72M
36M
0M
2020: 80M
80M
2020
2021: 115M (+44% vs 2020)
115M
+44%
2021
2022: 95M (-17% vs 2021)
95M
-17%
2022
2023: 100M (+5% vs 2022)
100M
+5%
2023
2024: 103M (+3% vs 2023)
103M
+3%
2024
EBITDA
SEK millions
30M
22M
15M
7M
0M
2020: 5M
5M
2020
2021: 24M (+380% vs 2020)
24M
+380%
2021
2022: 12M (-50% vs 2021)
12M
-50%
2022
2023: 2M (-83% vs 2022)
2M
-83%
2023
2024: 5M (+150% vs 2023)
5M
+150%
2024
Income statement
SEK thousands
Item
2024
2023
2022
2021
2020
Revenue
102 711
99 574
95 241
115 018
80 105
Staff expenses
—
—
—
—
—
EBITDA
5 200
2 362
12 352
23 632
4 586
Depreciation & amort.
—
—
—
—
—
EBIT
5 200
2 362
12 352
23 632
4 586
Net financials
−1 279
−1 423
−4 741
−1 188
−1 198
Profit before tax
113
53
5 894
8 266
−511
Tax
−72
−45
−1 100
−1 282
−32
Net profit
41
8
4 794
6 984
−543
Balance sheet
SEK thousands
Item
2024
2023
2022
2021
2020
Total assets
106 079
102 642
96 451
115 143
93 537
Equity
30 127
30 086
30 077
25 283
18 299
Long-term debt
2 924
5 239
3 830
25 681
23 285
Short-term debt
21 255
19 667
22 178
31 081
23 726
Total debt
24 179
24 906
26 008
56 762
47 011
Financial ratios
5-year trend
EBITDA margin
5,1 %
This company
15,8 %
Market median
This company
Market median
68% below market
2020
2024
Equity ratio
28,4 %
This company
38,2 %
Market median
This company
Market median
26% below market
2020
2024
Return on equity
0,1 %
This company
18,4 %
Market median
This company
Market median
99% below market
2020
2024
Net profit margin
0,0 %
This company
8,1 %
Market median
This company
Market median
100% below market
2020
2024
Asset turnover
0,97×
This company
1,12×
Market median
This company
Market median
13% below market
2020
2024
Debt / equity
2,52×
This company
0,62×
Market median
This company
Market median
306% above market
2020
2024
Annual reports & filings
Annual report 2024
Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
View
PDF
Annual report 2020
Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
View
PDF
More on Elos Medtech Timmersdala AB
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
